DE2527636A1 - Verfahren zur herstellung von mycobakteriellen fraktionen - Google Patents

Verfahren zur herstellung von mycobakteriellen fraktionen

Info

Publication number
DE2527636A1
DE2527636A1 DE19752527636 DE2527636A DE2527636A1 DE 2527636 A1 DE2527636 A1 DE 2527636A1 DE 19752527636 DE19752527636 DE 19752527636 DE 2527636 A DE2527636 A DE 2527636A DE 2527636 A1 DE2527636 A1 DE 2527636A1
Authority
DE
Germany
Prior art keywords
aqueous
water
mycobacterial
cells
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19752527636
Other languages
German (de)
English (en)
Inventor
Frank M Berger
Richard H Gustafson
Bernard John Ludwig
Jean-Pierre Rosselet
Gerald L Rowin
Herbert J Spencer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of DE2527636A1 publication Critical patent/DE2527636A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32—Mycobacterium

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE19752527636 1974-06-20 1975-06-20 Verfahren zur herstellung von mycobakteriellen fraktionen Pending DE2527636A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48145774A 1974-06-20 1974-06-20

Publications (1)

Publication Number Publication Date
DE2527636A1 true DE2527636A1 (de) 1976-01-08

Family

ID=23912017

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752527636 Pending DE2527636A1 (de) 1974-06-20 1975-06-20 Verfahren zur herstellung von mycobakteriellen fraktionen

Country Status (6)

Country Link
JP (1) JPS5132794A (enExample)
BE (1) BE830486A (enExample)
DE (1) DE2527636A1 (enExample)
FR (1) FR2275224A1 (enExample)
GB (1) GB1516507A (enExample)
NL (1) NL7507376A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153443B (da) * 1977-08-09 1988-07-18 Yuichi Yamamura Fremgangsmaade til fremstilling af fast farmaceutisk praeparat indeholdende cellevaegsskelet fra nocardia rubra

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5428830A (en) * 1977-08-09 1979-03-03 Ichirou Azuma Immunological treating agent of tumor containing glycolipid as effective component
JPS568320A (en) * 1979-07-04 1981-01-28 Chisato Maruyama Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent
CA1225592A (en) * 1983-08-26 1987-08-18 Ribi Immunochem Research Inc. Refined detoxified endotoxin
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
JP2522945B2 (ja) * 1987-06-18 1996-08-07 呉羽化学工業株式会社 抗レトロウィルス剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153443B (da) * 1977-08-09 1988-07-18 Yuichi Yamamura Fremgangsmaade til fremstilling af fast farmaceutisk praeparat indeholdende cellevaegsskelet fra nocardia rubra

Also Published As

Publication number Publication date
FR2275224B1 (enExample) 1979-08-10
GB1516507A (en) 1978-07-05
FR2275224A1 (fr) 1976-01-16
NL7507376A (nl) 1975-12-23
JPS5132794A (en) 1976-03-19
BE830486A (fr) 1975-12-22

Similar Documents

Publication Publication Date Title
DE3712768C2 (enExample)
DE3712767C2 (enExample)
DE69937343T2 (de) Adjuvanszusammensetzung und methoden zu deren verwendung
DE69524624T2 (de) Saponinzubereitungen und deren verwendung in iscoms
DE69826842T2 (de) Wässerige immunologische adjuvantzusammensetzungen aus monophosphoryllipid a
DE3833319C2 (enExample)
DE60037514T2 (de) Wässrige immunologische adjuvantzusammensetzungen aus monophosphoryllipid a
DE69724970T2 (de) Verfahren zur behandlung von hypersensitivität typ i unter verwendung von monophosphoryl-lipid a
DE69623072T3 (de) Impfstoffzusammensetzung für Säugetiere enthaltend Squalen oder Squalan, Phospholipid und ein Tensid als Adjuvans
DE69605094T2 (de) Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung
AT408445B (de) Neue attenuierte pseudomonas aeruginosa-stämme
DE2638762A1 (de) Wasserloesliche adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
CH640140A5 (de) Verfahren zur herstellung von intravenoes injizierbarem gamma-globulin.
DE2725204A1 (de) Immunitaets-stimulierendes medikament und verfahren zu seiner herstellung
DE3318568A1 (de) Therapeutische zusammensetzung enthaltend gereinigtes, entgiftetes endotoxin, trehalosedimycolat und ein mit azeton ausgefaelltes nebenprodukt von mit chloroform-methanol extrahierten endotoxischen glykolipiden
DE69730434T2 (de) Immunstimulierende lipidformulierung
DE2603321A1 (de) Emulsion auf der grundlage eines stoffwechselfaehigen pflanzlichen oels und wasser
DE2325299A1 (de) Aus mikroorganismen von der art der mycobakterien erhaltene, nicht-spezifische reizmittel, die eine antitumorimmunitaet hervorrufen und verfahren zu deren herstellung
DE2547105A1 (de) N-acetyl-muramyl-l-alanyl-d-isoglutamin enthaltende oelfreie adjuvanzien
DE3418820A1 (de) Arzneimittel fuer verdauungsgeschwuer
DE3516119A1 (de) Polyvalentes hyperimmunglobulin-praeparat
DE2823750C3 (de) Verfahren zur Gewinnung mindestens eines Hydrolyseprodukts eines Endotoxins von Bordetella Pertussis
DE2262427A1 (de) Immunostimulierendes mittel und verfahren zu dessen herstellung
DE2064296C2 (de) Verfahren zur Herstellung eines injizierbaren Mittels gegen Viren der Mäuseleukämien
DE69231724T2 (de) Fischimpfstoff gegen infektion mit aeromonas salmonicida

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee